Company Filing History:
Years Active: 2002-2007
Title: N Randall Chu: Innovator in HPV Immunotherapy
Introduction
N Randall Chu is a prominent inventor based in Victoria, Canada. He has made significant contributions to the field of immunotherapy, particularly in the development of treatments targeting human papillomavirus (HPV). With a total of five patents to his name, his work has the potential to impact cancer treatment and prevention.
Latest Patents
One of N Randall Chu's latest patents focuses on immune responses against HPV antigens. This patent describes compositions and methods for inducing an immune response to HPV antigens, which can be displayed by HPV or exhibited by infected cells, such as those from cervical and other tumors. The patent details how HPV proteins can be joined to stress proteins through various methods, including chemical conjugation and fusion. Additionally, it outlines expression vectors containing sequences encoding HPV antigens and stress proteins, which can be introduced into cells. These innovative compositions aim to enhance immune responses against HPV and associated tumors.
Career Highlights
N Randall Chu is affiliated with Stressgen Biotechnologies Corporation, where he continues to advance research in biotechnology and immunotherapy. His work has garnered attention for its potential to improve therapeutic strategies against HPV-related diseases.
Collaborations
Some of his notable coworkers include Lee A Mizzen and Huacheng Bill Wu, who contribute to the collaborative efforts in research and development within the company.
Conclusion
N Randall Chu's innovative work in HPV immunotherapy exemplifies the impact of dedicated inventors in the field of biotechnology. His patents and research continue to pave the way for advancements in cancer treatment and prevention.